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Theamyloid precursor protein (APP) and its proteolytic cleavage product Aβarewidely believed to be central to the
etiology of Alzheimer's disease (AD). APP and its family members are also essential for proper neuronal
development and homeostasis. APP is located at the cell surface and within intracellular compartments, cellular
regions that exhibit different pH values. The AD-associated amyloidogenic processing of APP is initiated
predominantly in intracellular acidic compartments, whereas its non-amyloidogenic cleavage is initiated at the cell
surface at slightly basic pH. We analyzed the influence of pH on the APP-E1 domain and found that its two
constituting subdomains, GFLD and CuBD, interact with each other in a pH-dependent manner. Dynamic light
scattering showed that APP-E1 represents a more open conformation at neutral pH and a more closed
conformation at acidic pH. Analyzing a 1.4 Å, high-resolution X-ray structure of E1 derived from merohedrally
twinned crystals resulted in the identification of individual residues that are responsible for these pH-dependent
interactions. Mutational studies and dynamic light scattering measurements further proved that specific hydrogen
bonds between the two carboxylates of D177 andE87, as well as betweenN89 andH147, aremajor determinants
of this pH-driven conformational switch in APP-E1. These findings show how APP can adopt different
conformations depending on pH and suggest that the protein fulfils different functions at distinct localizationswithin
the cell. Additionally, our data suggest a novel strategy for treating AD based on regulating the amyloidogenic
processing of APP by the specific interruption of the interaction between the APP-E1 subdomains.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by/3.0/).Introduction
The type I transmembrane protein amyloid precursor
protein (APP) and its proteolytic processing to the
neurotoxic Aβ peptide are generally believed to be
central to the etiology of Alzheimer's disease (AD).
APP is cleaved in two alternative pathways either by α-
and γ-secretase into the non-toxic fragments sAPPα,
p3 and the intracellular domain (AICD) or by β- and
γ-secretase into sAPPβ, the neurotoxic Aβ peptide
and AICD (e.g., reviewed in Refs. [1–3]). In addition,
various physiological functions are described for APP
including synaptic outgrowth [4], metal binding and
transport [5,6], regulation of gene transcription [7,8],
cell–cell interaction [9,10] or a receptor function [11].
Thus, APP also has an essential physiologic function
related to neuronal development and activity, althoughAuthors. Published by Elsevier Ltd. This
rg/licenses/by/3.0/).its exact cellular role and that of its two homologues,
the APP-like protein 1 (APLP1) and APP-like protein 2
(APLP2), remains to be established.
APP travels as a typical type I transmembrane pro-
tein during biosynthesis through the constitutive path-
way to the cell surface. Here it is also re-internalized
and transported to the lysosomal pathway or again
recycled into the secretory pathway (e.g., reviewed in
Ref. [12]). The cellular compartments largely differ in
their pH value, which typically is slightly basic at the cell
surface (pH ~7.4), slightly acidic (pH ~6.5–5.5) within
the secretory pathway and more acidic in endosomes
(pH ~5.7) or lysosomes (pH ~5.0) [13,14]. Interesting-
ly, the proteolytic processing of APP is different at
distinct parts of the cell: the β-secretase is predomi-
nantly active within the lysosomal compartments
and produces neurotoxic proteolysis fragments. Theis an open access article under the CC BY-NC-ND license
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Table 1. Data collection and refinement statistics
Data collection statistics
Unit cell parameters (Å)
a 91.4
b 91.4
c 80.0
Resolution range (Å)a 50–1.40 (1.47–1.40)
No. of reflections/unique reflections 357,235/70,655
Completeness (%)a 98.8 (97.7)
〈I/σ(I)〉a 16.8 (3.5)
Rmeas (%)
a,b 6.5 (47.3)
Multiplicitya 5.1 (4.9)
Refinement statistics
Resolution range (Å) 45.70–1.40 (1.4388–1.4151)
No. of reflections 75,220
Atoms protein/water 2519/626
434 pH-Dependent Structural Changes of APP-E1non-amyloidogenic processing of APP, however, is
initiated by α-secretase at the cell surface [2,15]. Thus,
the subcellular localization of APP has an influence on
its proteolytic processing and hence the generation of
the neurotoxic Aβ. As the subcellular location of α- and
β-secretase differs markedly in pH, this raises also the
question whether the different pH values affect the
structure of APP and with that its susceptibility to
processing by either α- or β-secretase. Interestingly,
not only the generation of Aβ but also its aggregation
seems to be pH dependent [16]. It could also be shown
that lowering the pHdoes influence the binding of Aβ to
heparan sulfate proteoglycans [17].
Over the last years, considerable progress in our
understanding of the structure of individual domains
of APP, their interaction within the entire protein and
their relation to certain physiologic functions of this
protein has been made (e.g., reviewed in Ref. [18]).
Its large ectodomain consists of the two rigidly folded
segments E1 [19] and E2 [6,20,21] that are
connected to one another and to the transmembrane
helix of APP by flexible segments called the acidic
domain and the juxtamembrane region, respectively
[22]. In turn, E1 consists of the subdomains growth
factor like (GFLD) and copper binding domain
(CuBD). They were initially described as individual
entities at neutral to slightly basic pH values between
7 and 8 [23–25]. Interestingly, these two constituent
subdomains tightly interact with each other specifi-
cally at the acidic pH of 5.0, now forming one
structural and functional unit, the E1 domain [19].
Interestingly, altered pH resulted also in different
interaction mode between APP-E1 and heparin in
isothermal titration calorimetry experiments [19].
To understand the pH-dependent behavior of the
APP-E1 domain, we analyzed its molecular shape at
different pH values by dynamic light scattering (DLS)
measurements and determined a highly resolved
crystal structure of this domain at 1.4 Å in a new
crystal form. We identified the responsible pH sensor
in APP-E1 by careful analysis of the high-resolution
structure and by comparative analyses of the
apparent molecular weight of wild-type (wt) E1 and
specific E1 mutants in solution. This mechanism
might represent a novel target to specifically interfere
with Aβ generation and hence potentially with the
development of AD.Rwork/Rfree (%)
a 15.6/18.6 (22.1/22.1)
Twin fraction 0.49
B-factors overall/protein/water/
Wilson plot (Å2)
15.7/14.6/20.3/19.8
Ramachandran plot (%)c 89.1/10.6/0.4/0
rmsd values of bond length (Å)/
bonded B values (Å2)
0.007/1.163
a Values given in parentheses represent the highest-resolution
shell. The values for the highest-resolution shell upon refinement
are given as provided by the Phenix output.
b Rmeas = ∑hkl[N/(N − 1)]1/2∑i|Ii(hkl) − (I(hkl)|/∑hkl∑iIi(hkl).
c Percentage of residues in most favored/additional allowed/
generously allowed/disallowed regions of the Ramachandran plot.Results
Trigonal APP-E1 crystals are almost
perfectly twinned
We expressed APP-E1 in Escherichia coli Origami
B (DE3), purified it to homogeneity using a three-step
purification protocol including His-tag cleavage
(Fig. S1) and used the respective protein for crystal-lization. We identified a new crystal form, which
resulted from a low-salt condition and diffracted to a
resolution of 1.4 Å. The data were merohedrally
twinned and the structure was solved by molecular
replacement (MR) using the entire E1 domain (PDB
ID: 3ktm [19]) as search model revealing two
molecules in the asymmetric unit (final Z-score of
29.4, LLG value of 1960.5 and R/Rfree of 45%/44%).
We refined the structure under consideration of the
found twinning operation (−h,−k,l) and always used
detwinned data for the calculation of electron density
maps. In addition, we checked for potential model
bias by calculating different omit maps (e.g., see
Fig. S2a), which always showed the electron density
for the omitted amino acids. The final model was built
in ~40 cycles of manual model building completing
also the loop between V47 and G50 of both
molecules in the asymmetric unit and the heparin
binding loop in molecule A (named according to PDB
file nomenclature). The latter section of molecule B
became not visible in the electron density map,
indicating high flexibility of this region. Refinement
was finished showing good R-factors, stereochem-
istry and electron density (Table 1 and Fig. S2b).
Overall structure of APP-E1 at high resolution
The overall fold of the E1 domain is very similar to
the previously described entire E1 domain (PDB ID:
3ktm [19]) (rmsd of 0.80 Å, calculated for all Cα atoms)
435pH-Dependent Structural Changes of APP-E1(Fig. 1). The higher resolution of 1.4 Å (as compared
to 2.7 Å for PDB ID: 3ktm [19]) does, however, allow a
much more detailed analysis of individual residues
and atoms than previously possible.
The high similarity also extends to the linker region
and to the molecular contacts between GFLD and
CuBD. The highly resolved E1 structure now clearly
shows the importance of individual amino acids for
the interaction of both subdomains. They contact
each other via a central hydrophobic core, the
previously identified salt bridge between D125 and
R116, several hydrogen bonds and additional polar
and water-mediated interactions. The largest differ-
ences between the rhombohedral APP-E1 crystals
(PDB ID: 3ktm [19]) and the herein determined
trigonal APP-E1 structure is found for the heparin
binding loop encompassing the segment between
C98 and C105 (Fig. 1). This section also shows the
highest B-factors of the entire E1 domain. Thus, this
section is characterized by a general tendency
toward flexibility. In order to test for similar structures
within the PDB, we compared the two subdomains
of E1 to all structurally known proteins within a
PDBeFold search [26]. Interestingly, our search
identified only the structures of the individually
determined GFLD (PDB ID: 1mwp [23]; rmsd of
0.8 Å) and the different CuBDs (PDB IDs: 2fjz, 2fk1,
2fk2, 2fk3 and 2fma [25,27]; rmsd of 0.52–0.91 Å) of
APP-E1 and APL-1 (PDB ID: 2m05; rmsd of 1.2 Å
[28]), indicating that both subdomains form rather
unique folds and are structurally not similar to other
known proteins.
We asked next if the previously determined dimeric
arrangement of APP-E1 [19] is present in the new
crystal form. Alternatively, the herein described
trigonal crystals might offer a different explanation for
the biochemically observed E1 dimerization by short
heparin chains [29]. To check for potential dimericarrangements, we analyzed interaction interfaces
using the PISA server [30] and identified exclusively
interfaces typical for weak molecular contacts usually
representing physiologically non-significant crystal
contacts (Table S1). None of these interfaces
(Fig. S3) contains a continuous, positively charged
surface patch as one would expect for a productive
dimeric interface that can be stabilized by its interac-
tion with negatively charged heparin molecules. Also
none of the observed contacts is in agreement with
previously observed amino acid residues and muta-
tions affecting the heparin-induced dimerization of
APP-E1 as, for example, residues of the heparin
binding loop between C98 and C105 [31] and herein
especially K103 and K106 [29]. We thus conclude that
the interactions between the different molecules in the
trigonal crystal do not represent contacts important for
the heparin-induced dimerization of APP-E1. The low
ionic strength of our present crystallization condition
probably prevents the formation of crystal contacts
involving the strongly positively charged loop between
C98 and C105 of the GFLD.
pH-dependent apparent molecular weight
of APP-E1
Our analysis focused next on the pH-dependent
structural and biochemical characteristics of APP-E1.
We performed DLS measurements of the E1 domain
in dependence of the protein concentration at pH 5.7
and at pH 7.4, corresponding to the pH values of
endosomes and of the plasma membrane, respec-
tively (Fig. 2). Independent of pH, we observed an
about 2-fold increase of the apparent molecular
weight of APP-E1 at high protein concentrations, in
accordance with a concentration-dependent dimer-
ization that was described before [29]. In addition, the
apparentmolecular weight of theAPP-E1domainwasFig. 1. Overall structure of APP-E1
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Fig. 2. DLSat different pHvalues. Theapparentmolecular
weight of APP-E1 was determined by DLS experiments
at two different pH values (pH 5.7 and pH 7.4) and at
increasing protein concentrations. Averages of three inde-
pendent experiments ± standard deviation are shown to-
gether with the statistical analysis of the observed differences
(*P b 0.005, **P b 0.001).
436 pH-Dependent Structural Changes of APP-E1at all protein concentrations significantly lower at
pH 5.7 than at pH 7.4. The determination of the
apparent molecular weight by DLS is based on the
hydrodynamic radius and hence the shape of the
analyte. Hereby, the overall shape of the molecule
depends on its oligomerization state and on its con-
formation. Because the observed pH-dependent
differences in the apparent molecular weight are
seen at all concentrations and hence do not depend
on it, one can exclude oligomerization as reason.
Accordingly, these data must originate from a more
open (and hence a larger hydrodynamic radius)
overall conformation at pH 7.4 (representing the cell
surface) than observed at the endosomal pH of 5.7.Fig. 3. Distinct pH-dependent interactions at the GFLD–
revealed three regions that are formed in a pH-dependent mann
to Fig. 1 and is shown in a cartoon representation. Interacting
shown in green and are contoured at 3.0 σ for those residues. (a
with the CuBD. (b) N89 of the GFLD builds up two hydrogen
therefore connects both subdomains with each other (c) the
broken lines and distances are given in angstroms (Å).pH-dependent interaction of GFLD and CuBD
We next analyzed the interface between the GFLD
and theCuBD for well-defined interactions (Fig. 3) and
compared it to various available structures of APP-E1
subdomains obtained at different pH values (Fig. 4).
Interestingly, structures of the whole E1 domain are
only available from crystals grown at acidic pH value
of 5.0–5.6 and, thus, the formal alignment of the entire
E1 domain at different pH is technically not possible.
Instead, we superimposed the structures of the two
individually solved E1 subdomains onto the entire
APP-E1 domain solved in this study. In particular, we
used the GFLD (PDB ID: 1mwp [23]) and the CuBD in
its ligand-free form (PDB ID: 2fjz [25]) that were both
solved at pH values between 7 and 8. In addition, we
also superimposed the isolated CuBD solved at acidic
pH (PDB ID: 2fk3 [25]), which served as internal
control to test for structural effects that solely originate
from the crystallization of the isolated subdomain.
In principle, found differences could result not only
from true pH-induced structural alterations but also
from artifacts resulting from different crystal packings.
Thus, any such structural comparison can only
suggest potential interactions that must be verified
by respectivemutational analyses later on. In general,
the overall fold of both subdomains in isolation is very
similar to their structures within the entire E1 domain
(Fig S4), which is also shown by the very low rmsd
values of the alignments. Comparing the structure of
theGFLD (1mwp) solved in isolation at pH 7.5with the
herein shown APP-E1 domain at low pH including
amino acids 28–123 resulted in an rmsd value of
0.457 Å. The alignment of the individually solved
CuBDs at different pH conditions ranging from 5.4 to
8 with the high-resolution structure of E1 including
residues 131–189 showed rmsd values of 0.358 ÅCuBD interface. Analysis of the GFLD–CuBD interface
er. The high-resolution structure of E1 is colored according
residues are depicted as sticks and Fo − Fc omit maps are
) N84 of the GFLD interacts via backbone hydrogen bonds
bonds with H147 and Y168 of the CuBD at acidic pH and
E87-D177 interaction. Hydrogen bonds are indicated by
437pH-Dependent Structural Changes of APP-E1and0.443 Å for 2fjz and 2fk3, respectively. In contrast,
the structure of the interface and the contacts between
the two subdomains did show major pH-dependent
differences.
First, we analyzed the interface areas in between the
GFLD and the CuBD at different pH values employing
the PISA server [30] to calculate interaction interfaces.
The interface area between the subdomains of the
herein shown high-resolution E1 structure at pH 5.6
comprised 366 Å2. This is very similar to the interface
area of the previously obtained E1 structure [19]
showing an interface area of 371 Å2 (this area is
smaller than the originally published value as it had to
be recalculated for this study without the contribution of
the linker region, which is not present for the
individually solved subdomain structures). This inter-
face size is also comparable to the one between the
herein shown GFLD (solved at pH 5.6) and the
individually solved CuBD structure determined at
pH 5.4 (PDB ID: 2fk3), which was calculated to
374 Å2. Interestingly, the interaction area decreased
by 15–20% to 318 Å2 between the two at slightly basic
pH individually solved GFLD (pH 7.5) and CuBD
(pH 8.0) structures, superimposed onto the entire
APP-E1. This reduction in interface area goes along
with a reduced number of distinct interactions. Where-
as five hydrogen bonds stabilize the interaction at
pH 5.6, the same interface does not contain any
hydrogen bond if created by superposition with the
structures at high pH.
We next analyzed the conformation of the interact-
ing residues in detail in order to understand the
observed differences (Figs. 3 and 4). The section
responsible for the largest change in interface is a loop
of the CuBD encompassing the residues L172–F179,
with residues C174–D177 showing the largest con-
formational changes (Figs. 3a and 4a). Interestingly,
also a disulfide bridge is part of these structural
alterations. C174 is differently oriented at pH 8.0
compared to pH 5.5/5.6, affecting the conformation
of its disulfide linkage to C144. The location of G175
also largely affects the interaction between GFLD and
CuBD.Ahydrogen bondbetween this residue (located
within theCuBD) andN84 (locatedwithin theGFLD) is
only present at pH 5.5/5.6 but not at pH 8.0. Further-
more, the residues I176 and D177 of the CuBD are in
direct contact with the GFLD only at acidic pH.
The second contact between GFLD and CuBD is
formed by the imidazole ring of H147 only acting as
hydrogen bond donor to N89 at acidic pH (Fig. 3b).
At neutral pH, however, deprotonation of H147
abolishes this interaction. In addition, the side-chain
carboxamide nitrogen of N89 forms a hydrogen bond
to the main-chain carbonyl oxygen of Y168 (CuBD)
and cannot substitute as a possible hydrogen bond
donor to a deprotonated H147. Instead, the ring
plane of H147 is rotated by ~90° at pH 8.0 now
forming an alternative hydrogen bond to the tyrosyl
functionality of Y168 (Figs. 3b and 4b). This newhydrogen bond lies within the CuBD and hence does
not stabilize any inter-subdomain contact.
Another interesting contact is formed between E87
of the GFLD and D177 of the CuBD, which face each
other directly with their side-chain carboxylates
(Figs. 3c and 4c). This conformation is well defined in
the 1.4 Å crystal structure of the entire E1 domain at
lowpHand showsadistanceof 2.71 ÅbetweenD177-
OD2 and E87-OE1. This can only be explained by a
pKa shift and the existence of a tight hydrogen bond
between the two carboxylates. Otherwise, the two
negatively charged side chains would strongly repel
each other. In fact, respective contacts have been
studied extensively [32] and theauthorsdescribeapKa
shift of up to ~2.5 pH units. Considering the side-chain
pKa values of aspartate (3.90) and glutamate (4.32),
only amoderate shift in pKa is necessary to forma tight
hydrogen bond between the two carboxylates at acidic
pH. At higher pH, the two carboxylates are deproto-
nated and repel each other.
Interestingly, all here described residues (E87,
N89, H147, Y168 and D177) are conserved between
APP and APLP2 of different vertebrates, but mostly
not in vertebrate APLP1 and in the APP homologues
of the two model organisms,Caenorhabditis elegans
and Drosophila melanogaster (Fig. S5). This con-
servation pattern has been noted before [19] and
further supports the notion that the interaction
between the GFLD and the CuBD within APP-E1 is
of functional relevance for vertebrate APP and
APLP2, but probably not for APLP1 and evolutionary
distant APP homologues.Mutations in the pH-dependent interface
influence the conformational change of E1
Based on our structural investigation, we created
specific interface mutants to analyze if the respective
residues are truly responsible for the pH-dependent
interaction between GFLD and CuBD. In particular,
we analyzed the pH-dependent apparent molecular
weight of wt-APP-E1, the APP-E1_D177A and
APP-E1_N89A mutants (destroying the hydrogen
bonds between D177 and E87, as well as between
H147 and N89), the double mutant APP-E1_D177A/
N89A and the previously described mutant APP-E1_
H147N [33] by DLS. The latter mutant is especially
interesting as it was shown to affect the trafficking of
APP and has been implicatedwith the binding of Cu2+
to the CuBD of E1. Only the wt protein showed hereby
the expected pH-dependent difference of apparent
molecular weight, corresponding to ~29 kDa at the
slightly basic pH of 7.4 and ~20 kDa at the vesicular
pH of 5.7 (Fig. 5). All mutants show, in contrast, a
largely reduced effect on the apparent molecular
weight at the lower pH. Whereas for all mutants, the
apparent molecular weight at pH 7.4 is within the
experimental error identical with the wt protein, this
Fig. 4 (legend on next page)
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Fig. 5. DLS of different APP-E1
mutants at two pH values. Determination
of the apparent molecular weight of
APP-E1 and its interface mutants at a
concentrationof 0.6 mg/ml andat the two
different pH values.Whereas wt-APP-E1
showed a roughly 28% difference in the
apparentmolecular weight at different pH
values, basically no such change can
be seen within the experimental error
for all used mutants. Averages of three
independent experiments ± standard
deviation are shown together with the
statistical analysis of the observed differ-
ences (**P b 0.001, n.s. = not significant,
#P = 0.012).
439pH-Dependent Structural Changes of APP-E1value is not largely reduced upon lowering the pH
(Fig. 5). The observed small differences between the
individual mutants, especially for the N89A mutation,
might hereby be interpreted as different importance of
the respective contact for the pH-dependent interac-
tion. This shows that all mutants are not able anymore
to form the specific hydrogen bonds between CuBD
and GFLD. Both interactions, the atypical hydrogen
bond between the carboxylates of E87 and D177 as
well as the hydrogen bond between H147 and N89,
are required to stabilize the tight interaction between
the two subdomains forming APP-E1 at vesicular pH.Discussion
The APP is central to neuronal development
and the etiology of the neurodegenerative AD. It is
located both at the cell surface and within intracel-
lular compartments. Both subcellular localizations
differ markedly in their pH, potentially linking different
physiological functions or properties of APP to
different pH values. Interestingly, a pH-dependent
behavior of APP-E1 was already found in solution
during limited proteolysis and isothermal titration
calorimetry measurements, where the ratio of protein
to heparin changed from 2:1 at pH 7.4 to 1:1 at
pH 5.7 [19]. To analyze the structural differences of
the E1 domain at different pH values, we herein
solved the crystal structure of this domain at theFig. 4. Alignment of E1 structures solved at different pH values. Stereo-r
high-resolution structure of E1 solved at pH 5.6 (colored according to Fig.
subdomains. The individually solved GFLD at pH 7.5 (PDB ID: 1mwp [23]) is
(PDB ID: 2fjz [25]) is in orange and the CuBD solved at pH 5.4 (PDB ID: 2fk3
between atoms are depicted as black broken lines. (a) The loop region b
pH-dependent conformational differences. (b) H147 and N89 are rotated in a
generation of two hydrogen bonds that increase the interaction of both subd
hydrogen bond between H147 and Y168 is formed within the CuBD only at
other directly and form a hydrogen bond only at acidic pH. In the individually s
pH, both residues are oriented in opposite directions.high-resolution limit of 1.4 Å in a new crystal form
that turned out to be almost perfectly twinned.
Crystals were grown under a low-salt condition,
and the structure was determined using MR and
refined to good-quality factors. It shows an overall
fold similar to the previously determined structure of
the entire APP-E1 (PDB ID: 3ktm [19]). The higher
resolution allows, however, a detailed analysis of
pH-induced conformational changes at the interface
between the subdomains GFLD and CuBD that, in
addition, were also characterized biochemically.
The presented DLS experiments showed a con-
centration-dependent self-dimerization of APP-E1 at
both pH values that fit nicely to the already character-
ized heparin-dependent and heparin-independent
dimerization of this protein [29]. Interestingly, the
apparent molecular weight of the E1 domain is
significantly lower at pH 5.7 than at pH 7.4, strongly
supporting a more open and flexible conformation of
E1 at higher pH as already suggested before [19]. We
investigated this aspect in more detail and found by
structural and biochemical studies that the total
interface area depends on pH. We also identified
several key residues that together form a molecular
explanation for the observed pH dependence of the
interaction between the GFLD and the CuBD within
APP-E1. Due to the different orientations especially of
N89, H147, E87 and D177 and their pH-dependent
protonation, several hydrogen bonds across the
interface can only be formed at acidic but not atepresentation of the alignment between the
1) and structures of the individually solved
shown in cyan, the CuBD solved at pH 8.0
[25]) is in purple. Specific hydrogen bonds
etween C174 and K178 shows the largest
pH-dependent manner, which leads to the
omains at acidic pH. In contrast to this, the
the higher pH. (c) E87 and D177 face each
olved GFLD and CuBD structures at higher
440 pH-Dependent Structural Changes of APP-E1neutral pH. Consequently, the interaction of both
subdomains decreases with increasing pH. This was
confirmed by mutational studies together with DLS
experiments, which showed that exchanging the here
identified residues resulted in the loss of strong
contacts between the two subdomains constituting
E1 at acidic pH and, therefore, a permanently more
open conformation of all E1 mutants at both pH
values. This pH-dependent interaction explains also
why our crystals of the entire E1 were only stably
under acidic conditions and dissolved when we
attempted to increase the pH beyond ~6.5.
Thus, the E1 domain of APP apparently adopts a
more closed conformation in lysosomal vesicles at pH
~5.7 where β-secretase is localized. A more opened
conformation is expected to be predominant at the cell
surface with a pH of ~7.4 accompanied by an
increased apparent molecular weight. Interestingly,
previous studies showed a significant effect of the
H147Nmutation on the proteolytic processing of APP
resulting in decreasedAβ production [33]. Thismutant
also showed evidence of an altered cellular localiza-
tion due to decreased post-Golgi trafficking and
therefore strongly hints toward the biological impor-
tance of the here investigated pH-induced conforma-
tional changes and mutations. Our data show that, on
the structural level, the H147N mutation impairs the
pH-dependent interaction of GFLD and CuBD. Based
on these results, we propose a pH sensor within the
E1 domain, finally regulating the proteolytic process-
ing of APP. Trafficking of APP to the cell surface and
subsequent re-internalization is an essential step for
amyloidogenic cleavage of APP by β- and γ-secre-
tase. pH-triggered structural alterations of E1 might
directly regulate the interaction of APP to proteins that
affect its cellular localization and, therefore, its
susceptibility for β-secretase action.
Taken together, the herein investigated amino acid
side chains E87, N89, H147 and D177 and the loop
segment C174–D177 trigger the tight interaction
between GFLD and CuBD at acidic pH. Reducing
this interaction could be a highly specific approach to
reduce the amyloidogenic processing of APP and
hence of medical interest for the treatment of AD.Materials and Methods
Cloning
The APP-E1 domain without His-tag was cloned,
expressed and purified as previously described [19,34].
The four different mutants of E1 were generated from the
E1 wt clone [19] by site-directed mutagenesis employing
primer pairs corresponding to the following sequence and
expressed and purified as the wt protein:
N89A 5 ′ -GTGGTAGAAGCCGCTCAACCAGTGA
CCATC-3′D177A 5 ′ -GCCCTGCGGAATTGCCAAGTTCCG
CGGGGTAGAGTTTGTG-3′
H147N 5′-GATGTTTGCGAAACTAATCTTCACTGGCA-
CACCGTCGCGAAAGAGACATGC -3′
Success of the mutagenesis was checked by sequenc-
ing (Source BioScience LifeSciences).Crystallization and data collection
Crystals were grown by the sitting-drop vapor diffusion
method at 10 °C from 0.1 M Na-citrate (pH 5.6), 20%
polyethylene glycol 4000, 11% 2-propanol and 10 mM
sarcosine. Therefore, equal volumes of 10 mg/ml protein
and reservoir solution were mixed in 24-well plates (MVD/
24; Charles Supper). Within 2–3 days, rod-shaped crystals
grew to a size of around 500 μm × 50 μm × 30 μm. The
crystals were transferred to reservoir solution supplement-
ed with 5% R(−)-2-methyl-2,4-pentandiole for flash cool-
ing. X-ray data were collected at 100 K and 0.918 Å
wavelength at the synchrotron (Helmholtz Zentrum Berlin,
BESSY II, BL14.1) [35] up to 1.4 Å resolution (Table 1).Crystallographic data analysis, structure building
and refinement
The crystallographic dataset was processed using the
XDSAPP 0.21 software [36,37]. Initially, space group
P6222 and after identification of the twin-law P3221 were
used for processing. The test set for Rfree was chosen in
thin shells using XDLDATAMAN [38]. The phase problem
was solved employing MR with the entire E1 structure
(PDB ID: 3ktm [19]) and the program Phaser [39] as
implemented in ccp4i 6.3.0 program suite [40]. For MR
residues, V47–G50 and C98–H108 were removed from
the search model. MR in space group P3221 showed two
molecules in the asymmetric unit. Since both pseudotran-
slation and twinning could result in the apparent presence
of an additional symmetry axis, we performed twin analysis
with Phenix xtriage [41] and CNS 1.3 [42] and determined
the very high twin fraction of 49.7% together with the twin
operation −h,−k,l. We also analyzed the resolution
dependency of quality factors during data reduction in
space group P6222 to test for pseudosymmetry, which we
could clearly not observe. Next, 40 cycles of manual
model building using Coot [43] followed by a twin-based
combined positional, twin fraction and B-factor refinement
using Phenix 1.8.1 [41] and considering NCS restraints
(automatic mode) were performed. During this refinement,
the missing loop between V47–G50 in both molecules and
the loop encompassing the residues C98–C105 in
molecule A were completed. Electron density maps were
always calculated after detwinning (both CNS 1.3 [42]).
Structure and sequence analysis
PyMOL (DeLano Scientific LLC†) was used for rmsd
calculation, visualization of molecules and structure com-
parisons. Electrostatic surface potentials were calculated
with APBS [44]. For analysis of interaction interfaces, the
PISA server [30] was used. For the calculation of interface
areas, the E1 structures were divided into the GFLD (amino
441pH-Dependent Structural Changes of APP-E1acids 28–120) and the CuBD (amino acids 131–189). For
the other usedstructures of theGFLD (PDB ID: 1mwp) or the
CuBD (PDB ID: 2fjz), the same amino acid range was used,
except for 2fk3 where only the residues 133–189 were
available from the PDB. Searching for structurally similar
proteins was performed using PDBeFold provided by the
European Bioinformatics Institute [26]. To check for conser-
vation, we generated an alignment using ClustalX 2.1 [45].Dynamic light scattering
DLS experiments were performed using a DLS 802
instrument (Viskotek) at different protein concentrations.
Themeasurements were performed in 14 μl and 45 μl quartz
cuvettes (Hellma Analytics) at protein concentration higher
and lower than 2.5 mg/ml, respectively. All data were
collected at 20 °C with a duration time of 5 s and 50
acquisitions. For the measurements, buffers containing
150 mM NaCl and 5 mM Na3PO4 at pH 5.7 and pH 7.4
wereused.Allmeasurementswereperformed in triplicate and
the evaluation of the data was performed using the OmniSize
software (Viskotek) according to the manufacturer's recom-
mendation. For statistical analysis, a two-tailed, unpaired t test
was performed using Microsoft Excel. P values higher than
0.05 were considered as not significant differences.Data deposition
The atomic coordinates and structure factors have been
deposited in the Protein Data Bank‡, under the accession
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